America in Transition Pages

Friday, August 12, 2016

FDA Sees No General Safety Risk With FAAH Inhibitors

(MedPage Today) -- Brain damage in French trial probably not a class effect, agency says

from MedPage Today Washington Watch http://ift.tt/2aQNAqN
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)